跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,112 条关于
“ATG-207”
全部
11,112
临床试验
5,742
药物
2,682
机构
347
资讯
2,341
昨天
Antengene Doses First Patient in Pivotal Phase III CLINCH-3 Study of CLDN18.2 ADC ATG-022
8个月前
Alto Neuroscience Secures Key Patent for ALTO-207 Depression Treatment, Extending IP Protection to Mid-2040s
6个月前
UCB Secures $1.1B License for Antengene's Masked T-Cell Engager ATG-201 in Autoimmune Disease Push
去年
CorestemChemon Partners with ATG Lifetech to Advance Organoid-Based Preclinical Testing
上个月
Alto Neuroscience Expands ALTO-207 Phase 3 Program in Treatment-Resistant Depression, Backed by $100 Million Financing
9个月前
Antengene Receives NMPA Approval for Phase Ib/II Study of ATG-022 CLDN18.2 ADC in Combination with Pembrolizumab for Gastric Cancer
去年
Antengene to Showcase Six Innovative Cancer Therapies at AACR and ASCO 2025
去年
Low-Dose Antithymocyte Globulin Shows Promise for Type 1 Diabetes Treatment in Youth
24年前
Early Antithymocyte Globulin Therapy Enhances Survival in Steroid-Resistant Acute GVHD Patients
2年前
SAB Biotherapeutics' SAB-142 Shows Promising Safety Profile in Type 1 Diabetes Trial
第 1 页,共 235 页
上一页
下一页